Lantern Pharma LTRN

$ 2.95 0.0%

Quarterly report 2024-Q3
added 11-07-2024

Lantern Pharma Balance Sheet 2011-2024 | LTRN

Annual Balance Sheet Lantern Pharma

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-51.3 M	-19.1 M	-1.23 M	-445 K	-	-	-	-	-	-	-
Long Term Debt	61.5 K	-	52.9 K	108 K	-	-	-	-	-	-	-	-	-
Long Term Debt Current	173 K	52.9 K	152 K	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	108 K	-	-	-	-	-	-	-	-	-
Total Current Liabilities	2.68 M	2.8 M	2.33 M	552 K	-	-	-	-	-	-	-	-	-
Total Liabilities	2.74 M	2.8 M	2.38 M	661 K	489 K	652 K	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-55.2 M	-39.3 M	-25 M	-12.7 M	-6.75 M	-4.32 M	-	-	-	-	-	-	-
Total Assets	43.6 M	58.8 M	74 M	20.4 M	1.43 M	450 K	-	-	-	-	-	-	-
Cash and Cash Equivalents	21.9 M	37.2 M	51.5 M	19.2 M	1.23 M	-	-	-	-	-	-	-	-
Book Value	40.9 M	56 M	71.6 M	19.7 M	943 K	-202 K	-	-	-	-	-	-	-
Total Shareholders Equity	40.9 M	56 M	71.6 M	19.7 M	943 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Lantern Pharma

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	94 K	54.7 K	61.5 K	107 K	151 K	141 K	-	-	-	13.3 K	52.9 K	92 K	131 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	3.7 M	4.66 M	2.74 M	2.36 M	3.17 M	2.93 M	2.8 M	3.14 M	5.3 M	3.09 M	2.38 M	1.88 M	2.82 M	773 K	661 K	661 K	661 K	661 K	489 K	489 K	489 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-70.2 M	-65.6 M	-55.2 M	-51.1 M	-47.9 M	-43.2 M	-39.3 M	-35.9 M	-33.6 M	-29.1 M	-25 M	-21.5 M	-17.4 M	-15.1 M	-12.7 M	-12.7 M	-12.7 M	-12.7 M	-6.75 M	-6.75 M	-6.75 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	30.3 M	35.6 M	43.6 M	47.8 M	51.4 M	55.5 M	58.8 M	62.2 M	66.4 M	68.4 M	74 M	77.6 M	82.4 M	82.5 M	20.4 M	20.4 M	20.4 M	20.4 M	1.43 M	1.43 M	1.43 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	8.1 M	13 M	21.9 M	25.6 M	28.4 M	32.5 M	37.2 M	39.3 M	43.4 M	46.7 M	51.5 M	54.7 M	61.4 M	81.4 M	19.2 M	19.2 M	19.2 M	19.2 M	1.23 M	1.23 M	1.23 M	-	445 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	26.6 M	30.9 M	40.9 M	45.4 M	48.3 M	52.6 M	56 M	59 M	61.1 M	65.3 M	71.6 M	75.7 M	79.6 M	81.7 M	19.7 M	19.7 M	19.7 M	19.7 M	943 K	943 K	943 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	26.6 M	30.9 M	40.9 M	45.4 M	48.3 M	52.6 M	56 M	59 M	61.1 M	65.3 M	71.6 M	75.7 M	79.6 M	81.7 M	19.7 M	19.7 M	19.7 M	19.7 M	943 K	943 K	943 K	1.74 M	-202 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency